ArticleFrontiers in oncology2026
HMC-net: a ResNet fused hierarchical multi-scale cross-attention architecture for mammographic breast malignancy recognition incorporating explainable AI.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate and understandable interpretation of mammograms is fundamental to dependable identification of breast cancer, which facilitates clinical trust and usefulness. The framework proposed in this paper is known as the ResNet50HierarchicalMultiScaleCross-Attention (HMC) Network, building upon ResNet50 by embedding Hierarchical Self Attention and Multi-Scale Cross Attention modules for enriched feature representation toward mammogram-based detection of breast cancer. Intra-layer self-attention together with inter-layer cross-attention may enable the model to learn local as well as global patterns and hence improve performance for classification tasks on the MIAS dataset. For explainability issues, Grad-CAMs, Grad-CAM++, and Score-CAM are included in the architecture. Such methods yield heatmaps whose more clinically relevant regions can be made explicit for automated diagnostics to become transparent and trusted. With a 5-fold cross-validation run, it attained a mean accuracy of 0.9972 (± 0.05), a mean precision value of 0.9851 (± 0.13), a recall of 0.9899 (± 0.19), F1-score that amounted to 0.9864 (± 0.07). The values for AUC-ROC and specificity were found to be quite high at 0.99(± 0.01) and about 0.9978(± 0.09), respectively, basically beating most baseline models like ResNet50, VGG19, VGG16, and ViT among others in performance metrics variance as indicated by the Friedman test (p-value=0.002< 0.05). Between ResNet50 with Hierarchical Attention, ResNet50 with Multi-Scale Attention, and the proposed model using the Nemenyi
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.